Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Neuromuscular taping in multiple sclerosis. A pilot study.
Rebound of disease activity during pregnancy after withdrawal of fingolimod.
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
Newly diagnosed multiple sclerosis in state of Qatar.
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
Homophilic interaction of the L1 family of cell adhesion molecules.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Can smoking aggravate my multiple sclerosis symptoms?
A randomized trial of stress management for the prevention of new brain lesions in MS.
CNS myelin wrapping is driven by actin disassembly.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, th17- and activated B-cells and correlates with progression.
Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Strategies for myelin regeneration: lessons learned from development.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.

Pages